ChristopherPatrickCarrollMD

PubMed

• 3 citations
  Chronic Pain: Prevalence and Management.
  Christopher P Carroll, Amanda M Brandow> ;Hematology/oncology Clinics of North America. 2022 Dec 1
• 3 citations
  Preliminary evidence that hydroxyurea is associated with attenuated peripheral sensitization in adults with sickle cell disease
  Janelle E. Letzen, Sophie Lanzkron, Kasey Bond, Christopher Patrick Carroll, Jennifer A. Haythornthwaite, Sabrina Nance, Claudia M. Campbell> ;Pain Reports. 2019 Mar 22
• Daily Opioid Use Fluctuates as a Function of Pain, Catastrophizing, and Affect in Patients With Sickle Cell Disease: An Electronic Daily Diary Analysis.
  Finan, P. H.,Carroll, C. P.,Moscou-Jackson, G.,Martel, M. O.,Campbell, C. M.,Pressman, A.,Smyth, J. M.,Tremblay, J. M.,Lanzkron, S. M.,Haythornthwaite, J. A.> ;J Pain. 2017 Sep 26
• 25 citations
  Disease-Related, Nondisease-Related, and Situational Catastrophizing in Sickle Cell Disease and Its Relationship With Pain.
  Vani A. Mathur, Kasey B. Kiley, C. Patrick Carroll, Robert R. Edwards, Sophie Lanzkron, Jennifer A. Haythornthwaite, Claudia M. Campbell> ;The Journal of Pain. 2016 Nov 1
• 3 citations
  Chronic and Noncrisis Pain in Sickle Cell Disease.
  Christopher Patrick Carroll> ;Southern Medical Journal. 2016 Sep 1
• Examination of the Patient and Hospitalization Characteristics of 30-Day SCD Readmissions.
  Carroll CP, Haywood C, Lanzkron SM> ;South. Med. J.. 2016-09-01
• Improving Inpatient Care for Individuals with Sickle Cell Disease Using the Project ECHO Model.
  Stewart RW, Whiteman LN, Strouse JJ, Carroll CP, Lanzkron S> ;South. Med. J.. 2016-09-01
• 8 citations
  Symptomatic Avascular Necrosis: An Understudied Risk Factor for Acute Care Utilization by Patients with SCD.
  Tiffany Yu, Timothy Campbell, Isabella V. Ciuffetelli, Carlton Haywood, Christopher Patrick Carroll, Linda Resar, John J. Strouse, Sophie Lanzkron> ;Southern Medical Journal. 2016 Sep 1
• Chronic Opioid Therapy and Central Sensitization in Sickle Cell Disease.
  Carroll CP, Lanzkron S, Haywood C, Kiley K, Pejsa M, Moscou-Jackson G, Haythornthwaite JA, Campbell CM> ;Am J Prev Med. 2016-07-01
• The Association between Educational Attainment and Patterns of Emergency Department Utilization among Adults with Sickle Cell Disease.
  Jonassaint CR, Beach MC, Haythornthwaite JA, Bediako SM, Diener-West M, Strouse JJ, Lanzkron S, Onojobi G, Carroll CP, Haywood C> ;Int J Behav Med. 2016-06-01
• Quantitative sensory testing and pain-evoked cytokine reactivity: comparison of patients with sickle cell disease to healthy matched controls.
  Campbell, C. M.,Carroll, C. P.,Kiley, K.,Han, D.,Haywood, C.,Lanzkron, S.,Swedberg, L.,Edwards, R. R.,Page, G. G.,Haythornthwaite, J. A.> ;Pain. 2015 Dec 30
• Multiple Levels of Suffering: Discrimination in Health-Care Settings is Associated With Enhanced Laboratory Pain Sensitivity in Sickle Cell Disease.
  Mathur, V. A.,Kiley, K. B.,Haywood, C.,Bediako, S. M.,Lanzkron, S.,Carroll, C. P.,Buenaver, L. F.,Pejsa, M.,Edwards, R. R.,Haythornthwaite, J. A.,Campbell, C. M.> ;Clin J Pain. 2016 Feb 19
• An evaluation of central sensitization in patients with sickle cell disease.
  Campbell, C. M.,Moscou-Jackson, G.,Carroll, C. P.,Kiley, K.,Haywood, C.,Lanzkron, S.,Hand, M.,Edwards, R. R.,Haythornthwaite, J. A.> ;J Pain. 2016 Feb 20
• Impact of a dedicated infusion clinic for acute management of adults with sickle cell pain crisis.
  Lanzkron, S.,Carroll, C. P.,Hill, P.,David, M.,Paul, N.,Haywood, C.> ;Am. J. Hematol.. 2015 Feb 03
• Perceived discrimination, patient trust, and adherence to medical recommendations among persons with sickle cell disease.
  Haywood, C.,Lanzkron, S.,Bediako, S.,Strouse, J. J.,Haythornthwaite, J.,Carroll, C. P.,Diener-West, M.,Onojobi, G.,Beach, M. C.> ;J Gen Intern Med. 2014 Sep 11
• Perceived discrimination in health care is associated with a greater burden of pain in sickle cell disease.
  Haywood C, Diener-West M, Strouse J, Carroll CP, Bediako S, Lanzkron S, Haythornthwaite J, Onojobi G, Beach MC> ;J Pain Symptom Manage. 2014-11-01
• Mortality rates and age at death from sickle cell disease: U.S., 1979-2005.
  Lanzkron S, Carroll CP, Haywood C> ;Public Health Rep. 2013-01-01
• Prediction of onset and course of high hospital utilization in sickle cell disease.
  Carroll, C. P.,Haywood, C.,Lanzkron, S.> ;J Hosp Med. 2011 Jun 11
• Maladaptive opioid use behaviors and psychiatric illness: what should we do with what we know?
  Carroll, C. P.,Haythornthwaite, J.> ;Curr Pain Headache Rep. 2011 Jan 29
• Examining the characteristics and beliefs of hydroxyurea users and nonusers among adults with sickle cell disease.
  Haywood C, Beach MC, Bediako S, Carroll CP, Lattimer L, Jarrett D, Lanzkron S> ;Am. J. Hematol.. 2011-01-01
• The burden of emergency department use for sickle-cell disease: an analysis of the national emergency department sample database.
  Lanzkron S, Carroll CP, Haywood C> ;Am. J. Hematol.. 2010-10-01
• The course and correlates of high hospital utilization in sickle cell disease: Evidence from a large, urban Medicaid managed care organization.
  Carroll CP, Haywood C, Fagan P, Lanzkron S> ;Am. J. Hematol.. 2009-10-01
• The Intensive Treatment Unit: A brief inpatient detoxification facility demonstrating good postdetoxification treatment entry.
  Carroll, C. P.,Triplett, P. T.,Mondimore, F. M.> ;J Subst Abuse Treat. 2009 Jan 20
• Comparison of demographic and clinical characteristics between opioid-dependent individuals admitted to a community-based treatment setting and those enrolled in a res...
  Carroll CP, Kidorf M, Strain EC, Brooner RK> ;J Subst Abuse Treat. 2007-12-01
• Join now to see all